Niiki Pharma - Niiki Pharma Inc.,Pharma

News and headlines about Niiki Pharma all over the world. Collection of breaking news from United States, Europe, Asia and other country to show news about Niiki Pharma,Niiki Pharma Inc..

• Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based...

  By Carolyn Rhinebarger on April 3, 2012 - Niiki Pharma presents preclinical data at the American Association for Cancer Research Annual Meeting in Chicago, Illinois for the first highly orally bioavailable... [+]

  gallium-based anti-cancer agent. Read more
  drug development       Niiki Pharma

• Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists

  By Carolyn Rhinebarger on February 1, 2012 - Niiki Pharma announced today the formation of its Scientific Advisory Board. Daniel Haller M.D. will chair the advisory board, and will be joined by Lee Ellis M.D.... [+]

  and Matt Kulke M.D. Read more
  GRP78       Niiki Pharma Inc.       oncolology product development

• Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer...

  By Carolyn Rhinebarger on January 18, 2012 - Niiki Pharma Inc. has completed the dose escalation portion of the Phase I clinical trial of its lead product, NKP-1339, a first-in-class anti-cancer treatment. ... [+]

  Read more
  Niiki Pharma       NKP1339

Latest news headlines about Niiki Pharma of US. Browse the following news to get noticed with trends, events and spotlight about Niiki Pharma,Niiki Pharma Inc..

• Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I...

  By Carolyn Rhinebarger on June 1, 2011 - Niiki Pharma will present Phase I clinical study data for its transferrin targeted ruthenium based anti-cancer compound, NKP-1339, at the 2011 American Society for... [+]

  Clinical Oncology meeting in Chicago, IL. Read more
  drug development       Niiki Pharma

Latest news headlines about Niiki Pharma of UK. Browse the following news to get noticed with trends, events and spotlight about Niiki Pharma,Niiki Pharma Inc..

• Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other...

  By Carolyn Rhinebarger on November 15, 2011 - A 2011 AACR-NCI-EORTC International Conference abstract demonstrated NKP-1339’s synergistic activity in both in vitro and in vivo preclinical models with a broad... [+]

  range of anti-tumor agents. Read more
  Niiki Pharma       oncology product development

Latest news headlines about Niiki Pharma of Canada. Browse the following news to get noticed with trends, events and spotlight about Niiki Pharma,Niiki Pharma Inc..

• Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer...

  By Carolyn Rhinebarger on September 20, 2011 - Phase I results show 25% of enrolled patients (six) exhibiting anti-tumor activity for at least 12 weeks. One patient with a carcinoid tumor has tumor regression,... [+]

  continuing on NKP-1339 for 70+ weeks. Read more
  Niiki Pharma       oncology product development       transferrin targeted ruthenium